NeoStem, Inc. develops proprietary cell therapy products. It is involved in: manufacturing cell therapy-based products; product and process development; cell and tissue processing; regulatory support, storage, distribution and delivery; and consulting services. The company also provides contract development and manufacturing services to clients advancing product candidates for regenerative medicine; adult stem cell collection and storage services; and therapy development utilizing T-cells for autoimmune and inflammatory conditions. For more information, visit the company’s website at www.neostem.com.